Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 2:19 AM
Ignite Modification Date:
2025-12-26 @ 12:50 AM
NCT ID:
NCT05061134
Group ID:
EG000
Title:
Main Study: Ceralasertib + Durvalumab
Description:
Participants received ceralasertib 240 milligrams (mg) orally twice daily (BD) for 7 consecutive days (Days 1 to 7), and on Day 8, participants received 1500 mg durvalumab as an intravenous (IV) infusion once in every 28 days. This 28-day cycle was repeated until progressive disease, unacceptable toxicity, withdrawal of consent, or if a study treatment discontinuation criterion was met.
Deaths Number Affected:
43
Deaths Number At Risk:
None
Serious Number Affected:
19
Serious Number At Risk:
97
Other Number Affected:
86
Other Number At Risk:
97
Study:
NCT05061134
Results Section:
NCT05061134
Adverse Events Module:
NCT05061134